BGA BioNeutra Global Corporation

0.0210USD0.0300 CAD · TSXV0.00%Mkt Cap: 974092 USDP/E: —

BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. T…

Key Statistics

Company
Market Cap974.09K USD
Enterprise Value5.69M USD
Revenue (TTM)7.59M USD
Gross Profit2.90M USD
Net Income (TTM)-1.47M USD
Revenue/Share0.16 USD
Last Price0.0210 USD
Fiscal Year EndDec 2023
MR QuarterSep 2024
Employees—
CountryCA
SectorConsumer Defensive
IndustryPackaged Foods
ISINCA09073L1067
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-23.29
EV/Revenue0.75
P/S0.13
P/B-0.17
EPS (TTM)-0.01 USD
EPS (Forward)—
52W Range
—
52W High0.0210 USD
52W Low0.0210 USD
Profitability
Gross Margin36.40%
Oper. Margin-7.43%
EBITDA Margin-3.22%
Profit Margin-18.52%
ROE34.03%
ROA-13.37%
ROIC—
ROCE-146.28%
Growth
Revenue Growth20.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF477.74K USD
CapEx (TTM)13.50K USD
FCF Margin-11.61%
FCF Yield-90.45%
Net Debt4.72M USD
Net Debt/EBITDA-19.30
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.23
Current Ratio0.35
Quick Ratio0.13
Book Value/Sh-0.12 USD
Cash/Share0.01 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.46.45M
Float45.92M
Insiders36.86%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short35
Short (prev mo.)35
Technical
SMA 500.0210 (-0.0%)
SMA 2000.0210 (-0.0%)
Beta0.74
S&P 52W Chg12.00%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)—
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0210 USD
BB Middle0.0210 USD
BB Lower0.0210 USD
BB Width0.00%
ATR (14)0.0000 USD
Vol Ratio (20d)—

About BioNeutra Global (CVE: BGA)

›

BioNeutra Global (CVE: BGA) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Packaged Foods industry, part of the Consumer Defensive sector.

The shares were at 0.0300 CAD on 18 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 0.0300 CAD to 0.0300 CAD, and it trades at the top of that range.

Its market capitalisation is 1.39M CAD.

BioNeutra Global reports return on equity of 34.0%, an operating margin of -7.4% and revenue up 20.3% year over year.

Its debt exceeds its cash by 6.75M CAD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health.